Is Hyperhomocysteinemia an Important Risk Factor of Cardiovascular Disease?
- 1 December 2003
- journal article
- review article
- Published by S. Karger AG in Pathophysiology of Haemostasis and Thrombosis
- Vol. 33 (5-6) , 345-347
- https://doi.org/10.1159/000083826
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- MTHFR 677C→T Polymorphism and Risk of Coronary Heart DiseaseJAMA, 2002
- Homocysteine and Risk of Ischemic Heart Disease and StrokeJAMA, 2002
- Demonstration of Rapid Onset Vascular Endothelial Dysfunction After HyperhomocysteinemiaCirculation, 1999
- Common Methylenetetrahydrofolate Reductase Gene Mutation Leads to Hyperhomocysteinemia but Not to Vascular DiseaseCirculation, 1998
- Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trialsBMJ, 1998
- Acute hyperhomocysteinaemia and endothelial dysfunctionThe Lancet, 1998
- Hyperhomocyst(e)inemia Is Associated With Impaired Endothelium-Dependent Vasodilation in HumansCirculation, 1997
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Multivariate Analysis of Risk Factors for Coronary Heart DiseaseCirculation, 1973
- The epidemiology of coronary heart diseaseJournal of Chronic Diseases, 1965